anonymous
Guest
anonymous
Guest
Sweet! Forward the profitability model, LRP, P/L, and effective discount rate 3-year projections to us. Also, please include the 6-month conversion rate and dollar loss on part d rebates for autoimmune products on formulary for the aforementioned payers. We need to know what dollars we must make up while avoiding antitrust violations, so throw in a portfolio COGS analysis too. Don’t forget to include your HHS negotiation analysis and how rebates from MFP products in class will supersede any ASP + 6% returns they may receive.
One more thing, send us your acid test and returns analysis to justify the payouts you requested. As always, we value your feedback.
You idiot. That’s not the responsibility of a sales rep. lol. It’s the responsibility of the marketing team or whatever you want to call them. If they can’t get the job done, fire them and get people who can. Or admit you have no idea what you’re doing. You don’t try to put it on the sales team. lol. That’s why this company is going nowhere. The fact you thought what you wrote was smart shows the type of fools we have at FK. No wonder nothing is getting done. Moron. lol